+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Active Implantable Medical Devices Market - Global Forecast 2026-2032- Product Image
Active Implantable Medical Devices Market - Global Forecast 2026-2032- Product Image
Sale

Active Implantable Medical Devices Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4905106
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Active Implantable Medical Devices Market is projected to reach USD 3.55 Billion in 2026. It is expected to continue growing at a CAGR of 11.14%, reaching USD 6.73 Billion by 2032.

The active implantable medical devices market covers electronically powered products that are fully or partly introduced into the body and intended to remain after the procedure, including cardiac pacemakers, implantable cardioverter defibrillators, neurostimulators, cochlear implants, implantable infusion pumps, ventricular assist devices, and implantable monitoring platforms. Demand is supported by verified clinical drivers: cardiovascular disease remains the leading global cause of death according to the WHO, while hearing loss, Parkinson’s disease, epilepsy, chronic pain, and diabetes continue to expand the addressable patient population for implantable therapies.

Market development is increasingly shaped by miniaturization, rechargeable batteries, MRI-conditional designs, remote monitoring, closed-loop stimulation, and biocompatible materials. Hospitals, specialty clinics, ambulatory surgical centers, and electrophysiology labs are prioritizing active implantable medical devices that improve outcomes, reduce revision procedures, and support long-term patient management across value-based healthcare systems.

Transformative Shifts in the Active Implantable Device Landscape

The active implantable medical devices landscape is shifting from hardware-centric implants toward connected, data-rich therapeutic systems. Cardiac rhythm management devices now integrate remote patient monitoring and automated alerts, while neurostimulation platforms increasingly support personalized programming for chronic pain, movement disorders, and epilepsy. Cochlear implant innovation is also moving toward improved speech processing, smaller external components, and better integration with digital hearing ecosystems.

Regulatory expectations are transforming product development and lifecycle management. The EU Medical Device Regulation has increased clinical evidence, post-market surveillance, and traceability requirements, while the U.S. FDA continues to emphasize cybersecurity, software validation, real-world evidence, and device safety. These changes favor manufacturers with strong quality systems, clinical data capabilities, secure software governance, and robust post-market monitoring processes.

Cumulative Impact of Artificial Intelligence on Implantable Devices

Artificial intelligence is becoming a high-impact enabler across active implantable medical devices, particularly in signal interpretation, therapy optimization, predictive maintenance, and remote monitoring workflows. AI-assisted analytics can help clinicians identify arrhythmia patterns, detect device performance anomalies, refine neurostimulation parameters, and prioritize patients who need intervention.

The cumulative impact of AI is operational as well as clinical. Manufacturers are using machine learning in design verification, battery performance modeling, manufacturing quality control, and post-market surveillance. However, responsible adoption depends on transparent algorithms, validated datasets, cybersecurity controls, human oversight, and regulatory alignment for software as a medical device and AI-enabled decision support.

Key Regional Insights Across Asia-Pacific, North America, Europe, and Emerging Markets

North America remains a leading region for active implantable medical devices due to high procedure volumes, strong reimbursement pathways, advanced electrophysiology infrastructure, and early adoption of remote patient monitoring. The United States anchors regional innovation through FDA-cleared cardiac rhythm management, neuromodulation, cochlear, implantable pump, and monitoring technologies, while Canada benefits from established hospital procurement, public health system demand, and structured specialty-care access.

Europe is shaped by strong clinical expertise, MDR-driven evidence requirements, and broad adoption of cardiac and neurostimulation therapies across major economies. Asia-Pacific is expanding as China, Japan, India, South Korea, and Australia invest in specialty care, aging-population management, digital health infrastructure, and domestic medtech capacity. Latin America, led by Brazil and Mexico, shows growing demand for implantable cardiac and hearing technologies but remains affected by reimbursement variability and uneven specialist access. The Middle East is advancing through tertiary-care investment, particularly in GCC health systems focused on cardiology, neurology, and medical tourism, while Africa presents long-term opportunity tied to infrastructure development, specialist training, public-private partnerships, and improved access to advanced surgical care.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

Within ASEAN, rising healthcare investment, expanding private hospital networks, and growing demand for specialty cardiology and audiology services are supporting adoption of implantable cardiac, hearing, and neurostimulation technologies, although affordability, reimbursement depth, and specialist availability remain key adoption factors. GCC countries are prioritizing advanced tertiary care, medical tourism, national health transformation strategies, and digital health infrastructure, creating favorable conditions for premium active implantable medical devices in cardiology, neurology, and hearing restoration.

The European Union is defined by harmonized regulatory oversight under MDR, strong clinical research networks, and reimbursement systems that reward demonstrated safety, clinical performance, and patient outcomes. BRICS markets combine large patient pools with increasing domestic manufacturing ambitions, especially in China, India, and Brazil, while Russia and South Africa remain influenced by procurement structures and access disparities. G7 countries continue to lead in high-value innovation, advanced clinical practice, remote monitoring adoption, and regulatory science. NATO-aligned markets benefit from resilient supply chain planning, cybersecurity focus, hospital modernization priorities, and heightened scrutiny of connected medical device security.

Key Country Insights for Major Active Implantable Device Markets

The United States leads in advanced active implantable medical device adoption, supported by specialized cardiac and neurological care, FDA pathways, remote monitoring penetration, and extensive clinical research activity. Canada demonstrates steady demand through public healthcare procurement and structured hospital access, while Mexico benefits from private hospital growth, medical tourism, and proximity to North American supply chains. Brazil is the largest Latin American opportunity, driven by cardiovascular disease burden, expanding specialty care, and established demand for cardiac rhythm management devices.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong demand for pacemakers, implantable cardioverter defibrillators, cochlear implants, ventricular assist devices, and neurostimulation systems, with Germany and France standing out for clinical capacity, reimbursement sophistication, and hospital-based technology adoption. Russia remains a complex market shaped by localization policies, procurement dynamics, and geopolitical constraints. In Asia-Pacific, China and India offer scale through large patient populations and expanding tertiary-care infrastructure, Japan and South Korea lead in advanced technology adoption and aging-population care models, and Australia maintains high clinical standards, specialist access, and uptake of advanced implantable therapies.

Actionable Recommendations for Active Implantable Device Leaders

Industry leaders should prioritize clinically differentiated active implantable medical devices that reduce complications, extend battery life, improve MRI compatibility, enhance device longevity, and enable secure remote monitoring. Investment in evidence generation is essential, including prospective studies, registries, real-world evidence, and health economic models that demonstrate reduced hospitalization, improved quality of life, and lower total cost of care.

Manufacturers should also strengthen cybersecurity-by-design, AI governance, supply chain resilience, regulatory intelligence, and clinician training. Partnerships with hospitals, payers, digital health providers, academic centers, and manufacturing partners can accelerate market access and support post-market performance. In emerging markets, tiered pricing, service support, local regulatory expertise, repair capacity, and physician education are critical to scaling adoption responsibly.

Research Methodology

This executive summary is developed using a structured secondary-research framework aligned with established healthcare market intelligence practices. Inputs include publicly available regulatory guidance, clinical practice trends, peer-reviewed literature, government health data, product approvals, reimbursement developments, healthcare infrastructure indicators, and recognized public health sources.

Insights are triangulated across demand drivers, technology trends, regional healthcare capacity, regulatory requirements, and competitive positioning. The methodology emphasizes verified qualitative and quantitative indicators rather than speculative claims, with attention to cardiovascular disease burden, neurological disorder prevalence, hearing health needs, implant procedure adoption, cybersecurity expectations, AI governance, and post-market safety requirements.

Conclusion: Connected Implantable Therapies Define the Next Growth Phase

Active implantable medical devices are moving into a new phase defined by connected care, AI-enabled intelligence, miniaturized engineering, remote monitoring, and stronger post-market accountability. The market is supported by durable clinical demand across cardiovascular, neurological, auditory, metabolic, and mobility-related conditions, as well as continued healthcare system focus on improved outcomes and long-term disease management.

Competitive advantage will increasingly depend on evidence-backed innovation, secure digital integration, regulatory readiness, clinical workflow fit, and regional execution. Organizations that combine clinical performance with patient-centered design, reliable supply chains, cybersecurity resilience, and scalable service models are best positioned to support adoption in mature and emerging healthcare systems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Active Implantable Medical Devices Market, by Device Type
7.1. Introduction
7.2. Cardiac Pacemaker
7.3. Cochlear Implant
7.4. Implantable Cardioverter Defibrillator
7.5. Infusion Pump
7.6. Neurostimulator
8. Active Implantable Medical Devices Market, by Technology
8.1. Introduction
8.2. Non-Rechargeable
8.3. Rechargeable
9. Active Implantable Medical Devices Market, by Patient Age Group
9.1. Introduction
9.2. Adult
9.3. Geriatric
9.4. Pediatric
10. Active Implantable Medical Devices Market, by Application
10.1. Introduction
10.2. Cardiology
10.2.1. Heart Failure Management
10.2.2. Heart Rhythm Management
10.3. Endocrinology
10.4. Neurology
10.4.1. Deep Brain Stimulation
10.4.2. Spinal Cord Stimulation
10.5. Otology
11. Active Implantable Medical Devices Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Active Implantable Medical Devices Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Active Implantable Medical Devices Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Active Implantable Medical Devices Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Advanced Bionics Corporation
16.3. Aleva Neurotherapeutics S.A.
16.4. Axonics Modulation Technologies, Inc.
16.5. Berlin Heart GmbH
16.6. BIOTRONIK SE & Co. KG
16.7. Boston Scientific Corporation
16.8. Calon Cardio Ltd.
16.9. CARMAT SA
16.10. Cochlear Limited
16.11. CVRx Inc.
16.12. Envoy Medical Corporation
16.13. Inspire Medical Systems, Inc.
16.14. Jarvik Heart, Inc.
16.15. LivaNova PLC
16.16. Medtronic plc
16.17. MED-EL Elektromedizinische Geräte GmbH
16.18. MicroPort CRM Corporation
16.19. MicroTransponder Inc.
16.20. Nevro Corp.
16.21. Nurotron Biotechnology Co., Ltd.
16.22. Oticon Medical A/S
16.23. Sonova Holding AG
16.24. SynCardia Systems LLC
16.25. William Demant Holding A/S
List of Figures
FIGURE 1. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CARDIAC PACEMAKER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CARDIAC PACEMAKER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL COCHLEAR IMPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL COCHLEAR IMPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL COCHLEAR IMPLANT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL INFUSION PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL INFUSION PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL INFUSION PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL NEUROSTIMULATOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL NEUROSTIMULATOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL NEUROSTIMULATOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL NON-RECHARGEABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL NON-RECHARGEABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL NON-RECHARGEABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL RECHARGEABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL RECHARGEABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL RECHARGEABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL HEART FAILURE MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL HEART FAILURE MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL HEART FAILURE MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL HEART RHYTHM MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL HEART RHYTHM MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL HEART RHYTHM MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL OTOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL OTOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL OTOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 87. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 90. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 96. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 99. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 105. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 107. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 108. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 109. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 110. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 111. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 112. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 113. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 114. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 123. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 125. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 126. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 127. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 128. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 129. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 130. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 131. AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 135. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 136. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 137. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 138. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 139. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 140. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 141. ASEAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 142. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 144. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 145. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 146. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 147. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 148. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 149. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 150. GCC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 160. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 162. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 163. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 164. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 165. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 166. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 167. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 168. BRICS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 169. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 171. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 172. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 173. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 174. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 175. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 176. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 177. G7 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 178. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 179. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 180. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 181. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 182. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 183. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 184. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 185. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 186. NATO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 187. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 188. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 189. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 190. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 191. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 192. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 193. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 194. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 195. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 196. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 197. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 198. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 199. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 200. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 201. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 202. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 203. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 204. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 205. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 206. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 207. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 208. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 209. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 210. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 211. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 212. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 213. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 214. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 215. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 216. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 217. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 218. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 219. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 220. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 221. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 222. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 223. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 224. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 226. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 227. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 228. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 231. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 232. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 233. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 234. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 235. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 236. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 237. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 238. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 239. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 240. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 241. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 242. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 243. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 244. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 245. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 246. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 247. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 248. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 249. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 250. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 251. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 252. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 253. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 254. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 255. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 257. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 258. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 259. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 260. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 261. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 262. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 263. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 264. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 265. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 266. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 267. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 268. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 269. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 270. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 271. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 272. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 273. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 274. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 275. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 276. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 277. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 278. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 280. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 281. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 282. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 283. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 284. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 285. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 286. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 287. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 288. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 289. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 290. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 291. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 292. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 293. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 294. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 295. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 296. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 298. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 299. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 300. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 301. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 302. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 303. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 304. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 305. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 306. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 307. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 308. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 309. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 310. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 311. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 312. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 313. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 314. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 316. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 317. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 318. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 319. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 320. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY NEUROLOGY, 2017-2032 (USD MILLION)
TABLE 321. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 322. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 323. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 324. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • Advanced Bionics Corporation
  • Aleva Neurotherapeutics S.A.
  • Axonics Modulation Technologies, Inc.
  • Berlin Heart GmbH
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Calon Cardio Ltd.
  • CARMAT SA
  • Cochlear Limited
  • CVRx Inc.
  • Envoy Medical Corporation
  • Inspire Medical Systems, Inc.
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • MED‑EL Elektromedizinische Geräte GmbH
  • MicroPort CRM Corporation
  • MicroTransponder Inc.
  • Nevro Corp.
  • Nurotron Biotechnology Co., Ltd.
  • Oticon Medical A/S
  • Sonova Holding AG
  • SynCardia Systems LLC
  • William Demant Holding A/S

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.55 Billion
Forecasted Market Value ( USD ) by 2032 $ 6.73 Billion
Compound Annual Growth Rate11.1%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Active Implantable Medical Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Active Implantable Medical Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Active Implantable Medical Devices - Global Strategic Business Report - Product Image

Active Implantable Medical Devices - Global Strategic Business Report

  • Report
  • 268 Pages
  • Global
From
Active Implantable Medical Devices Market Report 2026 - Product Image

Active Implantable Medical Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Bioelectric Medicine Market - Global Forecast 2026-2032 - Product Image

Bioelectric Medicine Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Implantable Medical Device Market - Global Forecast 2026-2032 - Product Image

Implantable Medical Device Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From

About the Active Implantable Medical Device Market

The Active Implantable Medical Device (AIMD) market is a subset of the medical device industry that focuses on the development and production of medical devices that are implanted into the body. These devices are designed to monitor, diagnose, and treat a variety of medical conditions. AIMDs are typically powered by batteries and are designed to be implanted for long-term use. Examples of AIMDs include pacemakers, implantable cardioverter defibrillators, neurostimulators, and drug delivery systems. AIMDs are regulated by the Food and Drug Administration (FDA) and must meet stringent safety and efficacy standards. The market is highly competitive, with a number of large companies competing for market share. Some of the major players in the AIMD market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and Biotronik. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.